These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9066654)

  • 21. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
    Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
    J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study.
    Terada T; Ohta T; Kitamura Y; Ashida K; Matsunaga Y
    Arch Pathol Lab Med; 1998 Jan; 122(1):42-6. PubMed ID: 9448015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
    Wielenga VJ; Heider KH; Offerhaus GJ; Adolf GR; van den Berg FM; Ponta H; Herrlich P; Pals ST
    Cancer Res; 1993 Oct; 53(20):4754-6. PubMed ID: 7691404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ; Rustgi AK
    Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are CD44 variant isoforms involved in human tumour progression?
    Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
    Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different expression of CD44, ICAM-1, and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in scid mice.
    Piselli P; Vendetti S; Vismara D; Cicconi R; Poccia F; Colizzi V; Delpino A
    Anticancer Res; 2000; 20(2A):825-31. PubMed ID: 10810361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder.
    Kong QY; Liu J; Chen XY; Wang XW; Sun Y; Li H
    Oncol Rep; 2003; 10(1):51-5. PubMed ID: 12469144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44 splice variants: expression during lymphocyte activation and tumor progression.
    Pals ST; Koopman G; Heider KH; Griffioen A; Adolf GR; Van den Berg F; Ponta H; Herrlich P; Horst E
    Behring Inst Mitt; 1993 Aug; (92):273-7. PubMed ID: 7504454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
    Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
    Li H; Guo L; Li JW; Liu N; Qi R; Liu J
    Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast.
    Sapino A; Bongiovanni M; Cassoni P; Righi L; Arisio R; Deaglio S; Malavasi F
    J Pathol; 2001 Jun; 194(2):254-61. PubMed ID: 11400156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
    Dehmel A; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologically different subgroups of invasive ductal carcinoma of the pancreas: Dpc4 status according to the ratio of intraductal carcinoma components.
    Takahashi H; Oda T; Hasebe T; Aoyagi Y; Kinoshita T; Konishi M; Nakagohri T; Inoue K; Takahashi S; Kawahira H; Monden M; Ochiai A
    Clin Cancer Res; 2004 Jun; 10(11):3772-9. PubMed ID: 15173084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.